Literature DB >> 17766066

Cause-specific mortality and cancer incidence rates in relation to urinary beta2-microglobulin: 23-year follow-up study in a cadmium-polluted area.

Kokichi Arisawa1, Hirokazu Uemura, Mineyoshi Hiyoshi, Satoru Dakeshita, Atsushi Kitayama, Hiroshi Saito, Midori Soda.   

Abstract

A longitudinal study was performed to investigate the associations of exposure to environmental cadmium (Cd) with cause-specific mortality and cancer incidence rates. The study population comprised 275 adults living in a Cd-polluted area, Nagasaki Prefecture, Japan. The follow-up period extended from 1982 to 2005 for the analysis of cancer mortality, and from 1985 to 2002 for the analysis of cancer incidence. In the study area, the daily Cd intake from foods had decreased after 1980-1983 because of the restoration of Cd-polluted rice fields. The mortality rate among those with urinary beta2-microglobulin (U-beta2M)>/=1000 microg/g creatinine was significantly higher than that of the Japanese population for death from causes other than cancer, but not for cancers (177 at the 95% confidence interval [CI] 94-303). From analysis within the Cd-polluted area, the age-adjusted rate ratio of cancer deaths associated with increased U-beta2M was 2.58 (95% CI 1.25-5.36). The incidence rate of cancer among those with U-beta2M>/=1000 microg/g creatinine was 1.38 (95% CI 0.69-2.47) times that of the regional reference rate. Within the Cd-polluted area, the age-adjusted rate ratio of developing cancer associated with high U-beta2M was 1.79 (95% CI 0.84-3.82). In summary, there was a significant association between U-beta2M excretion and cancer mortality. However, there was neither a significantly increased standardized incidence ratio of cancer, nor significant relationship between U-beta2M and cancer incidence rate, though the point estimates were higher than unity. Continued follow-up and investigation of a larger cohort may be required before drawing a conclusion for the association between exposure to environmental Cd and cancer risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766066     DOI: 10.1016/j.toxlet.2007.07.007

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Cadmium, environmental exposure, and health outcomes.

Authors:  Soisungwan Satarug; Scott H Garrett; Mary Ann Sens; Donald A Sens
Journal:  Cien Saude Colet       Date:  2011-05

2.  Renal tubular dysfunction increases mortality in the Japanese general population living in cadmium non-polluted areas.

Authors:  Yasushi Suwazono; Kazuhiro Nogawa; Yuko Morikawa; Muneko Nishijo; Etsuko Kobayashi; Teruhiko Kido; Hideaki Nakagawa; Koji Nogawa
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-06-18       Impact factor: 5.563

Review 3.  Cadmium, environmental exposure, and health outcomes.

Authors:  Soisungwan Satarug; Scott H Garrett; Mary Ann Sens; Donald A Sens
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

4.  Causes of death in patients with Itai-itai disease suffering from severe chronic cadmium poisoning: a nested case-control analysis of a follow-up study in Japan.

Authors:  Muneko Nishijo; Hideaki Nakagawa; Yasushi Suwazono; Kazuhiro Nogawa; Teruhiko Kido
Journal:  BMJ Open       Date:  2017-07-13       Impact factor: 2.692

5.  Biological activities of ginger against cadmium-induced renal toxicity.

Authors:  Sami A Gabr; Ahmad H Alghadir; Gehan A Ghoniem
Journal:  Saudi J Biol Sci       Date:  2017-08-18       Impact factor: 4.219

6.  Cadmium exposure and pancreatic cancer in south Louisiana.

Authors:  Brian G Luckett; L Joseph Su; Jennifer C Rood; Elizabeth T H Fontham
Journal:  J Environ Public Health       Date:  2012-12-24

7.  Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population.

Authors:  Tim S Nawrot; Etienne Van Hecke; Lutgarde Thijs; Tom Richart; Tatiana Kuznetsova; Yu Jin; Jaco Vangronsveld; Harry A Roels; Jan A Staessen
Journal:  Environ Health Perspect       Date:  2008-07-24       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.